Giant Biogene Holding Co. Ltd. engages in research, development, manufacture, and sale of bioactive material-based beauty and health products. The company was founded by Jian Ya Yan and Dai Di Fan on May 2000 and is headquartered in Xi'an, China.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 2367 is 51.25 HKD — it has decreased by −0.10% in the past 24 hours. Watch GIANT BIOGENE HLDG CO. LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange GIANT BIOGENE HLDG CO. LTD stocks are traded under the ticker 2367.
2367 stock has fallen by −0.49% compared to the previous week, the month change is a 4.38% rise, over the last year GIANT BIOGENE HLDG CO. LTD has showed a 53.21% increase.
We've gathered analysts' opinions on GIANT BIOGENE HLDG CO. LTD future price: according to them, 2367 price has a max estimate of 78.00 HKD and a min estimate of 56.51 HKD. Watch 2367 chart and read a more detailed GIANT BIOGENE HLDG CO. LTD stock forecast: see what analysts think of GIANT BIOGENE HLDG CO. LTD and suggest that you do with its stocks.
2367 reached its all-time high on Mar 22, 2023 with the price of 58.80 HKD, and its all-time low was 24.15 HKD and was reached on Nov 29, 2022. View more price dynamics on 2367 chart. See other stocks reaching their highest and lowest prices.
2367 stock is 2.17% volatile and has beta coefficient of 1.21. Track GIANT BIOGENE HLDG CO. LTD stock price on the chart and check out the list of the most volatile stocks — is GIANT BIOGENE HLDG CO. LTD there?
Today GIANT BIOGENE HLDG CO. LTD has the market capitalization of 52.01 B, it has decreased by −1.35% over the last week.
GIANT BIOGENE HLDG CO. LTD is going to release the next earnings report on Mar 31, 2025. Keep track of upcoming events with our Earnings Calendar.
2367 earnings for the last half-year are 1.04 HKD per share, whereas the estimation was 0.90 HKD, resulting in a 15.48% surprise. The estimated earnings for the next half-year are 1.05 HKD per share. See more details about GIANT BIOGENE HLDG CO. LTD earnings.
GIANT BIOGENE HLDG CO. LTD revenue for the last half-year amounts to 2.73 B HKD, despite the estimated figure of 2.43 B HKD. In the next half-year revenue is expected to reach 2.72 B HKD.
2367 net income for the last half-year is 1.07 B HKD, while the previous report showed 847.86 M HKD of net income which accounts for 25.65% change. Track more GIANT BIOGENE HLDG CO. LTD financial stats to get the full picture.
GIANT BIOGENE HLDG CO. LTD dividend yield was 1.35% in 2023, and payout ratio reached 29.21%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 25, 2024, the company has 1.16 K employees. See our rating of the largest employees — is GIANT BIOGENE HLDG CO. LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GIANT BIOGENE HLDG CO. LTD EBITDA is 2.19 B HKD, and current EBITDA margin is 46.70%. See more stats in GIANT BIOGENE HLDG CO. LTD financial statements.
Like other stocks, 2367 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GIANT BIOGENE HLDG CO. LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GIANT BIOGENE HLDG CO. LTD technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GIANT BIOGENE HLDG CO. LTD stock shows the buy signal. See more of GIANT BIOGENE HLDG CO. LTD technicals for a more comprehensive analysis. If you're still not sure, try looking for inspiration in our curated watchlists.